B Lymphocytes in Alzheimer’s Disease—A Comprehensive Review
- 23 June 2022
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 88 (4) , 1241-1262
Abstract
Alzheimer’s disease (AD) represents the most common type of neurodegenerative dementia and is characterized by extracellular amyloid-β (Aβ) deposition, pathologic intracellular tau protein tangles, and neuronal loss. Increasing evidence has been accumulating over the past years, supporting a pivotal role of inflammation in the pathogenesis of AD. Microglia, monocytes, astrocytes, and neurons have been shown to play a major role in AD-associated inflammation. However recent studies showed that the role of both T and B lymphocytes may be important. In particular, B lymphocytes are the cornerstone of humoral immunity, they constitute a heterogenous population of immune cells, being their mature subsets significantly impacted by the inflammatory milieu. The role of B lymphocytes on AD pathogenesis is gaining interest for several reasons. Indeed, the majority of elderly people develop the process of “inflammaging”, which is characterized by increased blood levels of proinflammatory molecules associated with an elevated susceptibility to chronic diseases. Epitope-specific alteration pattern of naturally occurring antibodies targeting the amino-terminus and the mid-domain of Aβ in both plasma and cerebrospinal fluid has been described in AD patients. Moreover, a possible therapeutic role of B lymphocytes depletion was recently demonstrated in murine AD models. Interestingly, active immunization against Aβ and tau, one of the main therapeutic strategies under investigation, depend on B lymphocytes. Finally. several molecules being tested in AD clinical trials can modify the homeostasis of B cells. This review summarizes the evidence supporting the role of B lymphocytes in AD from the pathogenesis to the possible therapeutic implications.Keywords
This publication has 227 references indexed in Scilit:
- Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s DiseasePLOS ONE, 2013
- Progranulin Is a Chemoattractant for Microglia and Stimulates Their Endocytic ActivityThe American Journal of Pathology, 2011
- Summary of cerebrospinal fluid routine parameters in neurodegenerative diseasesJournal of Neurology, 2010
- MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic outputProceedings of the National Academy of Sciences, 2010
- Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-β1Cell Stem Cell, 2010
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Peripheral B cell subsetsCurrent Opinion in Immunology, 2008
- B cells and aging: Balancing the homeostatic equationExperimental Gerontology, 2007
- miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurelyProceedings of the National Academy of Sciences, 2007
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991